Synovus Financial stock rating upgraded by Raymond James on strong results

Synovus Financial (SNV) received multiple analyst upgrades, notably Raymond James to Outperform with a $62 price target, following robust second-quarter 2025 results that significantly exceeded forecasts. The bank reported EPS of $1.48 and revenue of $593.7 million, driving a 28% year-over-year EPS growth and an increased 2025 outlook, fueled by strong loan production and improved fee income. Analysts highlight a benign credit environment and positive operating leverage, noting SNV shares have outperformed peers while still trading at a valuation discount, suggesting continued upside potential amid accelerating bank M&A.

Analysis

Synovus Financial (SNV) is demonstrating significant fundamental momentum, validated by multiple analyst upgrades following a robust second-quarter 2025 performance. The company decisively beat consensus estimates, reporting an EPS of $1.48 against a $1.26 forecast, which constitutes a 17.46% positive surprise and a 28% year-over-year growth. This earnings strength is underpinned by tangible operational improvements, including the highest loan production since Q3 2022, a slight expansion in net interest margin to 3.37%, and successful de-risking efforts that have positively impacted credit metrics. Consequently, management has increased its full-year 2025 outlook, now projecting 4-6% loan growth. The market has responded, with SNV shares gaining 40.7% since early April 2025, outperforming the BKX, BANK, and S&P 500 indices. Despite this run-up, Raymond James notes the stock still trades at a discount to peers on P/E and TBV multiples, suggesting further upside potential driven by projected positive operating leverage and an increased scarcity value in a market ripe for bank M&A.

Key Decisions for Investors

• Given the strong earnings beat, upwardly revised guidance, and multiple analyst upgrades, investors could view Synovus Financial favorably, as the combination of fundamental momentum and a valuation discount to peers suggests continued upside potential.
• It is crucial to monitor the execution of the company's 4-6% loan growth target and the stability of its net interest margin, as these metrics are central to the positive operating leverage thesis presented by analysts.
• The potential for Synovus to be an M&A target, given its 'scarcity value' in a consolidating banking sector, should be factored into valuation models as a potential catalyst beyond organic growth.